{
    "CVS": [
        {
            "symbol": "CVS",
            "time": 1706054400000000000,
            "displayTime": "Wednesday, January 24 2024",
            "title": "Tyson Foods Drops CVS For Upstart Pharmacy Benefit Manager - CNBC",
            "text": "Jan 24 (Reuters) - :TYSON FOODS DROPS CVS FOR UPSTART PHARMACY BENEFIT MANAGER - CNBC.TYSON DROPPED CVS HEALTH'S CAREMARK AND CHOSE PBM STARTUP RIGHTWAY TO MANAGE DRUG BENEFITS FOR ITS 140,000 EMPLOYEES STARTING THIS YEAR - CNBC."
        },
        {
            "symbol": "CVS",
            "time": 1704412800000000000,
            "displayTime": "Friday, January 5 2024",
            "title": "CVS Health Sees Medicare Advantage Membership Growing By At Least 800,000 In 2024",
            "text": "Jan 5 (Reuters) - CVS Health Corp <CVS.N>::COMPANY WILL REAFFIRM ITS PREVIOUSLY ANNOUNCED FULL-YEAR 2024 GAAP DILUTED EPS GUIDANCE OF AT LEAST $7.26.EXPECTS ITS FULL-YEAR 2023 ADJUSTED EPS TO BE IN UPPER HALF OF GUIDANCE RANGE OF $8.50 TO $8.70.WILL REAFFIRM ITS FULL-YEAR 2023 CASH FLOW FROM OPERATIONS GUIDANCE AT UPPER END OF ITS $12.5 BILLION TO $13.5 BILLION GUIDANCE RANGE.EXPECT OUR TOTAL MEDICARE ADVANTAGE (\"MA\") MEMBERSHIP TO GROW BY AT LEAST 800,000 IN 2024.COMPANY WILL REAFFIRM ITS PREVIOUSLY ANNOUNCED FULL-YEAR 2024 ADJUSTED EPS GUIDANCE OF AT LEAST $8.50.CVS HEALTH-  DURING Q4 2023, ENTERED INTO A $3.0 BILLION FIXED DOLLAR ACCELERATED SHARE REPURCHASE TRANSACTION, WHICH BECAME EFFECTIVE ON JAN 3, 2024.THOMAS F. COWHEY WILL RECEIVE A BASE SALARY OF $1 MILLION AS CHIEF FINANCIAL OFFICER.COMPANY WILL REAFFIRM ITS PREVIOUSLY ANNOUNCED FULL-YEAR 2024 CASH FLOW FROM OPERATIONS GUIDANCE OF AT LEAST $12.5 BILLION..FY2024 EARNINGS PER SHARE VIEW $8.52 -- LSEG IBES DATA.FY2023 EARNINGS PER SHARE VIEW $8.59 -- LSEG IBES DATA.Further company coverage: <CVS.N>. ((Reuters.Briefs@thomsonreuters.com;))."
        },
        {
            "symbol": "CVS",
            "time": 1707264000000000000,
            "displayTime": "Wednesday, February 7 2024",
            "title": "CVS Health Revises Fy24 Earnings Per Share Outlook To At Least $7.06 From At Least $7.26",
            "text": "Feb 7 (Reuters) - CVS Health Corp <CVS.N>::CVS HEALTH: QTRLY ADJUSTED EARNINGS PER SHARE $2.12 VERSUS LSEG IBES ESTIMATE $1.99.CVS HEALTH: QTRLY TOTAL REVENUE $93.81 BILLION VERSUS LSEG IBES ESTIMATE $90.40 BILLION.CVS HEALTH: QTRLY EARNINGS PER SHARE $1.58.FY2024 EARNINGS PER SHARE VIEW $8.49 -- LSEG IBES DATA.CVS HEALTH REVISES FY24 ADJUSTED EARNINGS PER SHARE OUTLOOK TO AT LEAST $8.30 FROM AT LEAST $8.50.CVS HEALTH REVISES FY24 EARNINGS PER SHARE OUTLOOK TO AT LEAST $7.06 FROM AT LEAST $7.26.CVS HEALTH REVISES FY24 CASH FLOW FROM OPERATIONS OUTLOOK TO AT LEAST $12.0 BILLION FROM AT LEAST $12.5 BILLION.CVS HEALTH: CVS PHARMACY PLANS TO LAUNCH CVS COSTVANTAGE TO COMMERCIAL PAYORS IN 2025.CVS HEALTH: CVS CAREMARK PLANS TO LAUNCH CVS CAREMARK TRUECOST IN 2025.CVS HEALTH: 10% INCREASE TO QTRLY SHAREHOLDER DIVIDEND. ((Reuters.Briefs@thomsonreuters.com;;))."
        },
        {
            "symbol": "CVS",
            "time": 1707264000000000000,
            "displayTime": "Wednesday, February 7 2024",
            "title": "CVS FY Adjusted EPS USD 8.74 Vs. IBES Estimate USD 8.61",
            "text": "Feb 07 (Reuters) - CVS FY EPS USD 6.47.:"
        },
        {
            "symbol": "CVS",
            "time": 1707264000000000000,
            "displayTime": "Wednesday, February 7 2024",
            "title": "CVS FY Adjusted EPS USD 8.74 Vs. IBES Estimate USD 8.61",
            "text": "Feb 07 (Reuters) - CVS FY EPS USD 6.47.:."
        },
        {
            "symbol": "CVS",
            "time": 1707264000000000000,
            "displayTime": "Wednesday, February 7 2024",
            "title": "CVS Health Says Updated Outlook Assumes Elevated Q4 Cost Will Carry Forward Into 2024",
            "text": "Feb 7 (Reuters) - CVS Health Corp <CVS.N>::CVS HEALTH SAYS, IN PRESENTATION SLIDES, THAT UPDATED OUTLOOK ASSUMES ELEVATED Q4 COST WILL CARRY FORWARD INTO 2024.CVS SAYS INCREASE IN Q4 MEDICAL COSTS DRIVEN BY HIGHER-THAN-EXPECTED VOLUMES OF OUTPATIENT CARE AND SUPPLEMENTAL BENEFITS SUCH AS VISION, DENTAL.CVS SAYS THROUGH JANUARY, THE NUMBER OF AETNA MEMBERS ENROLLED IN OAK STREET CLINICS HAS DOUBLED.Further company coverage: CVS.N. ((Reuters.Briefs@thomsonreuters.com;))."
        },
        {
            "symbol": "CVS",
            "time": 1708128000000000000,
            "displayTime": "Saturday, February 17 2024",
            "title": "CVS Outlook FY EPS USD 7.06",
            "text": "Feb 17 (Reuters) - CVS outlook FY adjusted EPS USD 8.3.:"
        },
        {
            "symbol": "CVS",
            "time": 1708128000000000000,
            "displayTime": "Saturday, February 17 2024",
            "title": "CVS Outlook FY EPS USD 7.06",
            "text": "Feb 17 (Reuters) - CVS outlook FY adjusted EPS USD 8.3.:."
        }
    ]
}